From atoms to systems: A cross-disciplinary approach to complement-mediated functions

Molecular Immunology

Volumn 41, Issue 2-3, 2004, Pages 153-164

  Mastellos, D ^a   Morikis, D ^b   Strey, C ^a   Holland, M C ^a   Lambris, J D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of California Riverside   (United States)

Author keywords

Complement; Compstatin; Evolution; Mass spectrometry; Proteomics; Regeneration; Therapeutics; Vaccinia

Indexed keywords

COMPLEMENT; COMPLEMENT INHIBITOR; COMPSTATIN; DEUTERIUM; HEXAPEPTIDE; HYDROGEN; LIGAND; UNCLASSIFIED DRUG;

BINDING AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFERENCE PAPER; DEVELOPMENT; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; ELECTRICITY; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LIVER REGENERATION; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MOLECULAR MIMICRY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REGENERATION; STEM CELL TRANSPLANTATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THERMODYNAMICS; TISSUE REGENERATION; VACCINIA VIRUS; VERTEBRATE; VIRUS;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HEMATOPOIESIS; HUMANS; LIVER REGENERATION; PROTEIN BINDING; PROTEOMICS; VIRUSES;

VACCINIA;

EID: 2442652977     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.03.016     Document Type: Conference Paper

References (81)

1. Anderson L., Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. 18:1997;533-537
2. Brockes J.P. Amphibian limb regeneration: rebuilding a complex structure. Science. 276:1997;81-87
3. Carel J.C., Myones B.L., Frazier B., Holers V.M. Structural requirements for C3d, g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265:1990;12293-12299
4. Chong S., Montello G.E., Zhang A., Cantor E.J., Liao W., Xu M.Q., Benner J. Utilizing the C-terminal cleavage activity of a protein splicing element to purify recombinant proteins in a single chromatographic step. Nucleic Acids Res. 26:1998;5109-5115
5. Clemenza L., Isenman D.E. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165:2000;3839-3848
6. Cooper A., Johnson C.M. Isothermal titration microcalorimetry. Methods Mol. Biol. 22:1994;137-150
7. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1996;1379-1383
8. Del Rio-Tsonis K., Tsonis P.A., Zarkadis I.K., Tsangas A.G., Lambris J.D. Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. J. Immunol. 161:1998;6819-6824
9. Diefenbach R.J., Isenman D.E. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2. J. Immunol. 154:1995;2303-2320
10. Fausto, N., Webber, E.M., 1994. Liver regeneration. In: Arias, I.M., Boyer, J.L., Fausto, N., Jacoby, W.B., Schachter, D.A., Shafritz, D.A. (Eds.), The Liver: Biology and Pathobiology. Raven Press, New York, pp. 1059-1084.
11. Fiane A.E., Mollnes T.E., Videm V., Hovig T., Hogasen K., Mellbye O.J., Spruce L., Moore W.T., Sahu A., Lambris J.D. Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor compstatin. Transplant. Proc. 31:1999a;934-935
12. Fiane A.E., Mollnes T.E., Videm V., Hovig T., Hogasen K., Mellbye O.J., Spruce L., Moore W.T., Sahu A., Lambris J.D. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation. 6:1999b;52-65
13. Fiane A.E., Videm V., Lambris J.D., Geiran O.R., Svennevig J.L., Mollnes T.E. Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model. Transplant. Proc. 32:2000;899-900
14. Furlong S.T., Dutta A.S., Coath M.M., Gormley J.J., Hubbs S.J., Lloyd D., Mauger R.C., Strimpler A.M., Sylvester M.A., Scott C.W., Edwards P.D. C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles. Immunopharmacology. 48:2000;199-212
15. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., Hollmann T.J., Casali P., Caroll M.C., Wetsel R.A., Lambris J.D., Holers V.M., Salmon J.E. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112:2003;1644-1654
16. Guthridge J.M., Rakstang J.K., Young K.A., Hinshelwood J., Aslam M., Robertson A., Gipson M.G., Sarrias M.R., Moore W.T., Meagher M., Karp D., Lambris J.D., Perkins S.J., Holers V.M. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg. Biochemistry. 40:2001;5931-5941
17. Holland M.C., Lambris J.D. A functional C5a anaphylatoxin receptor in a teleost species. J. Immunol. 172:2004;349-355
18. Huber-Lang M.S., Riedeman N.C., Sarma J.V., Younkin E.M., McGuire S.R., Laudes I.J., Lu K.T., Guo R.F., Neff T.A., Padgaonkar V.A., Lambris J.D., Spruce L., Mastellos D., Zetoune F.S., Ward P.A. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16:2002;1567-1574
19. Isaacs S.N., Argyropoulos E., Sfyroera G., Mohammad S., Lambris J.D. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein. J. Virol. 77:2003;8256-8262
20. Kalli K.R., Ahearn J.M., Fearon D.T. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J. Immunol. 147:1991;590-594
21. Kimura Y., Madhavan M., Call M.K., Santiago W., Tsonis P.A., Lambris J.D., Rio-Tsonis K. Expression of complement 3 and complement 5 in newt limb and lens regeneration. J. Immunol. 170:2003;2331-2339
22. Klegeris A., Singh E.A., McGeer P.L. Effects of C-reactive protein and pentosan polysulphate on human complement activation. Immunology. 106:2002;381-388
23. Klepeis J.L., Floudas C.A. Ab initio tertiary structure prediction of proteins. J. Global Optimization. 25:2003;113-140
24. Klepeis J.L., Floudas C.A., Morikis D., Lambris J.D. Predicting peptide structures using NMR data and deterministic global optimization. J. Comput. Chem. 20:1999;1354-1370
25. Klepeis J.L., Floudas C.A., Morikis D., Tsokos C.G., Argyropoulos E., Spruce L., Lambris J.D. Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. J. Am. Chem. Soc. 125:2003;8422-8423
26. Klepeis J.L., Schafroth H.D., Westerberg K.M., Floudas C.A. Deterministic global optimization and ab initio approaches for the structure prediction of polypeptides, dynamics of protein folding, and protein-protein interactions. Comput. Methods Protein Folding Adv. Chem. Phys. 120:2002;265-457
27. Kotwal G.J., Isaacs S.N., Mckenzie R., Frank M.M., Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science. 250:1990;827-830
28. Kotwal G.J., Moss B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature. 335:1988;176-178
29. Lambris J.D. The multifunctional role of C3, the third component of complement. Immunol. Today. 9:1988;387-393
30. Lambris, J.D., Holers, V.M. (Eds.), 2000. Therapeutic interventions in the complement system, Humana Press, Inc., Totowa, NJ.
31. Lee, Y.L., Lee, K.F., Xu, J.S., He, Q.Y., Chiu, J.F., Lee, W.M., Luk, J.M., Yeung, W.S., 2004. The embryotrophic activity of oviductal cell derived complement C3b and iC3b-a novel function of complement protein in reproduction. J. Biol. Chem. 279, 2071-2078.
32. Lowell C.A., Klickstein L.B., Carter R.H., Mitchell J.A., Fearon D.T., Ahearn J.M. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170:1989;1931-1946
33. Lubinski J., Wang L., Mastellos D., Sahu A., Lambris J.D., Friedman H.M. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 190:1999;1637-1646
34. Madhavan, M.C., Kimura, Y., Call, M.K., Santiago, W., Tsonis, P.A., Lambris, J.D., Del Rio-Tsonis K., 2003. Do complement molecules play a role in lens regeneration? Invest. Ophthalmol. Vis. Sci. 44 (Abstract).
35. Mallik B., Lambris J.D., Morikis D. Conformational interconversion in compstatin probed with molecular dynamics simulations. Proteins. 53:2003;130-141
36. Mandell J.G., Falick A.M., Komives E.A. Identification of protein-protein interfaces by decreased amide proton solvent accessibility. Proc. Natl. Acad. Sci. U.S.A. 95:1998a;14705-14710
37. Mandell J.G., Falick A.M., Komives E.A. Measurement of amide hydrogen exchange by MALDI-TOF mass spectrometry. Anal. Chem. 70:1998b;3987-3995
38. Marino R., Kimura Y., De Santis R., Lambris J.D., Pinto M.R. Complement in urochordates: cloning and characterization of two C3-like genes in the ascidian Ciona intestinalis. Immunogenetics. 53:2002;1055-1064
39. Mastellos D., Lambris J.D. Complement: more than a 'guard' against invading pathogens? Trends Immunol. 23:2002;485-491
40. Mastellos D., Papadimitriou J.C., Franchini S., Tsonis P.A., Lambris J.D. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166:2001;2479-2486
41. Mastellos, D., Prechl, J., László, G., Papp, K., Oláh, E., Argyropoulos, E., Franchini, S., Tudoran, R., Markiewski, M., Lambris, J.D., Erdei, A., 2004. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol. Immunol. 40, 1213-1221.
42. Mckenzie R., Kotwal G.J., Moss B., Hammer C.H., Frank M.M. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1992;1245-1250
43. Mollnes T.E., Brekke O.L., Fung M., Fure H., Christiansen D., Bergseth G., Videm V., Lappegard K.T., Kohl J., Lambris J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 100:2002;1869-1877
44. Moore M.D., DiScipio R.G., Cooper N.R., Nemerow G.R. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J. Biol. Chem. 264:1989;20576-20582
45. Morikis D., Assa-Munt N., Sahu A., Lambris J.D. Solution structure of Compstatin, a potent complement inhibitor. Protein Sci. 7:1998;619-627
46. Morikis D., Lambris J.D. Structural aspects and design of low-molecular-mass complement inhibitors. Biochem. Soc. Trans. 30:2002;1026-1036
47. Morikis, D., Lambris, J.D., 2004. The electrostatic nature of C3d-CR2 association. J. Immunol., in press.
48. Morikis D., Roy M., Sahu A., Troganis A., Jennings P.A., Tsokos G.C., Lambris J.D. The structural basis of compstatin activity examined by structure-function-based design of peptide analogs and NMR. J. Biol. Chem. 277:2002;14942-14953
49. Morikis, D., Sahu, A., Moore, W.T., Lambris, J.D., 1999. Design, structure, function and application of compstatin. In: Matsukas, J., Mavromoustakos, T. (Eds.), Bioactive Peptides in Drug Discovery and Design: Medical Aspects. Ios Press, Amsterdam, pp. 235-246.
50. Muller-Eberhard H.J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:1988;321-347
51. Mullick J., Bernet J., Singh A.K., Lambris J.D., Sahu A. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 77:2003;3878-3881
52. Nagar B., Jones R.G., Diefenbach R.J., Isenman D.E., Rini J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science. 280:1998;1277-1281
53. Nilsson B., Larsson R., Hong J., Elgue G., Ekdahl K.N., Sahu A., Lambris J.D. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood. 92:1998;1661-1667
54. Paczkowski N.J., Finch A.M., Whitmore J.B., Short A.J., Wong A.K., Monk P.N., Cain S.A., Fairlie D.P., Taylor S.M. Pharmacological characterization of antagonists of the C5a receptor. Br. J. Pharmacol. 128:1999;1461-1466
55. Pennington S.R., Wilkins M.R., Hochstrasser D.F., Dunn M.J. Proteome analysis: from protein characterization to biological function. Trends Cell Biol. 7:1997;168-173
56. Pinto M.R., Chinnici C.M., Kimura Y., Melillo D., Marino R., Spruce L.A., De Santis R., Parrinello N., Lambris J.D. CiC3-1a-mediated chemotaxis in the deuterostome invertebrate Ciona intestinalis (Urochordata). J. Immunol. 171:2003;5521-5528
57. Prota A.E., Sage D.R., Stehle T., Fingeroth J.D. The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10641-10646
58. Ratajczak, J., Reca, R., Kucia, M., Majka, M., Allendorf, D.J., Baran, J.T., Janowska-Wieczorek, A., Wetsel, R.A., Ross, G.D., Ratajczak, M.Z., 2004. Mobilization studies in mice deficient in either C3 or C3a-receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 103, 1213-1221.
59. Reca R., Mastellos D., Majka M., Marquez L., Ratajczak J., Franchini S., Glodek A., Honczarenko M., Spruce L.A., Janowska-Wieczorek A., Lambris J.D., Ratajczak M.Z. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood. 101:2003;3784-3793
60. Rosengard A.M., Liu Y., Nie Z., Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. U.S.A. 99:2002;8808-8813
61. Sahu A., Kay B.K., Lambris J.D. Inhibition of human complement by a C3-binding peptide isolated from a phage displayed random peptide library. J. Immunol. 157:1996;884-891
62. 1 inactives the alternative complement pathway. J. Immunol. 160:1998;5596-5604
63. Sahu A., Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology. 49:2000;133-148
64. Sahu A., Lambris J.D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180:2001;35-48
65. Sahu A., Morikis D., Lambris J.D. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Mol. Immunol. 39:2003;557-566
66. Sahu A., Soulika A.M., Morikis D., Spruce L., Moore W.T., Lambris J.D. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165:2000;2491-2499
67. Sarrias M.R., Franchini S., Canziani G., Argyropoulos E., Moore W.T., Sahu A., Lambris J.D. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167:2001;1490-1499
68. Smith D.L., Deng Y.Z., Zhang Z.Q. Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry. J. Mass Spectrom. 32:1997;135-146
69. Soulika A.M., Khan M.M., Hattori T., Bowen F.W., Richardson B.A., Hack C.E., Sahu A., Edmunds L.H. Jr., Lambris J.D. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin. Immunol. 96:2000;212-221
70. Soulika A.M., Morikis D., Sarrias M.R., Roy M., Spruce L.A., Sahu A., Lambris J.D. Studies of structure-activity relations of complement inhibitor compstatin. J. Immunol. 171:2003;1881-1890
71. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198:2003;913-923
72. Strey, C.W., Winters, M., Markiewski, M., Sfyoera, G., Lambris, J.D., 2004. A proteomic analysis of liver regeneration: signaling-pathways, acute phase response, and lipid metabolism change after partial hepatectomy in mice. Presented at the American Transplant Congress, Boston, MA, May 2004.
73. Sun X., Funk C.D., Deng C., Sahu A., Lambris J.D., Song W.C. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 96:1999;628-633
74. Sunyer J.O., Tort L., Lambris J.D. Structural C3 diversity in fish - characterization of five forms of C3 in the diploid fish Spans aurata. J. Immunol. 158:1997;2813-2821
75. Sunyer J.O., Zarkadis I.K., Sahu A., Lambris J.D. Multiple forms of complement C3 in trout, that differ in binding to complement activators. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8546-8551
76. Szakonyi G., Guthridge J.M., Li D., Young K., Holers V.M., Chen X.S. Structure of complement receptor 2 in complex with its C3d ligand. Science. 292:2001;1725-1728
77. Taub R., Greenbaum L.E., Peng Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin. Liver Dis. 19:1999;117-127
78. Tsonis P.A., 1996. Limb Regeneration. Cambridge University Press, Cambridge, UK.
79. Tsonis P.A. Regeneration in vertebrates. Dev. Biol. 221:2000;273-284
80. Yamada Y., Kirillova I., Peschon J.J., Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1441-1446
81. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:1998;595-599